Oral Session 3-11B CML: Clinical (1)

[OS3-11B-5] Smoking influences the outcomes of patients receiving TKIs for CML in the chronic phase

Noriyoshi Iriyama¹, Michihide Tokuhira², Eriko Sato³, Keiji Sugimoto⁴, Tomoiku Takaku⁵, Maho Ishikawa⁶, Tomonori Nakazato⁷, Hiroyuki Fujita⁸, Yuta Kimura², Isao Fujioka⁵, Norio Asou⁶, Norio Komatsu⁵, Masahiro Kizaki², Yoshihiro Hatta¹, Tatsuya Kawaguchi⁹ (1.Hematol & Rheumatol., Nihon Univ., Tokyo, Japan, 2.Saitama Medical Center, Saitama Medical University, Saitama, Japan, 3.Juntendo University Nerima Hospital, Tokyo, Japan, 4.Juntendo University Urayasu Hospital, Urayasu, Japan, 5.Juntendo University School of Medicine, Tokyo, Japan, 6.Saitama Medical University International Medical Center, Saitama, Japan, 7.Yokohama Municipal Citizen's Hospital, Yokohama, Japan, 8.Saiseikai Yokohama Nanbu Hospital, Yokohama, Japan, 9.Kumamoto Health Science University, Kumamoto, Japan)